Clinical Trial Update: Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of bortezomib and topotecan in patients with advanced solid tumors, including lung cancer, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Bortezomib (bortezomib)
• Topotecan (topotecan)

Snippet

Sponsor: University of California, Davis | Conditions: Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED